- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Edward Boyer: Immediate and Long-term Respiratory Effects of the Ohio Train Derailment
Edward W. Boyer, MD, PhD, medical toxicologist, The Ohio State University, discusses respiratory health risks associated with chemical exposure after the train derailment in East Palestine, Ohio.
Immediate and long-term repsiratory health risks of the Ohio train derailment are going to be individualized, and will not effect everyone, says Edward Boyer, MD, PhD, medical toxicologist, emergency medicine physician, and professor of emergency medicine at The Ohio State University.
Transcript
What are the immediate and long-term health risks associated with exposure to the chemicals vinyl chloride and butyl acrylate?
The immediate health risks are pretty benign. I mean, you can have a little bit of respiratory irritation from chemical exposure that is going to be, I think, predominantly individualized; it won't necessarily affect everybody at low concentrations. But the immediate effects are going to be respiratory, maybe shortness of breath, maybe some cough, as well as dermal exposure if there was contact on the skin—that can manifest as a rash.
But long-term exposure for vinyl chloride, though, is much better defined. It's a known cause of specific types of cancers; specifically, sarcomas of the liver and other liver neoplasms. There's not much described about butyl acrylate long-term exposure. And like I said, for vinyl chloride, the long-term exposure is predominantly related to liver effects, cancers of the liver.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
